eramide,
Azaron,
Histantin,
Pyribenzamine,
Tripelennamine,
Tripelennamine Citrate,
Tripelennamine Citrate (1:1),
Tripelennamine Hydrochloride,
Tripelennamine Maleate,
Tripelennamine Maleate (1:1),
Tripelennamine Monohydrochloride,
Vetibenzamin,
CHLORCYCLIZINE HYDROCHLORIDE,
CHLORCYCLIZINE HCl,
Histantin,
Eramide,
Perazil,
1620-21-9,
Di-Paralene,
Chlorcyclizinium chloride,
14362-31-3,
Chlorcyclizine chloride,
Chlorcyclizine monohydrochloride,
EINECS 238-335-1,
NSC 169496,
Chlorcyclizine (hydrochloride),
1-(p-Chlorobenzhydryl)-4-methylpiperazine monohydrochloride,
1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine monohydrochloride,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, monohydrochloride,
(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine),
Di-Paralene monohydrochloride,
1-((4-Chlorophenyl)(phenyl)methyl)-4-methylpiperazine hydrochloride,
SMR001233306,
Chlorcylizine,
1-[(4-chlorophenyl)(phenyl)methyl]-4-methylpiperazine hydrochloride,
1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine;hydrochloride,
SR-05000001920,
Chlorcyclizine hydrochloride [USP],
Prestwick_967,
component of Fedrazil,
Ah-289 hydrochloride,
Diparalene hydrochloride,
NCGC00016589-01,
CAS-1620-21-9,
AC1L1X2Q,
Chlorocyclizine hydrochloride,
DSSTox_CID_25360,
DSSTox_RID_80825,
DSSTox_GSID_45360,
MLS002153967,
MLS006010796,
SCHEMBL321657,
CHEMBL1889091,
DTXSID7045360,
CTK8F8588,
MSIJLVMSKDXAQN-UHFFFAOYSA-N,
HMS1570M13,
Pharmakon1600-01500175,
1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine hydrochloride,
Tox21_110511,
MFCD00035329,
NSC169496,
NSC756678,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, hydrochloride,
Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, hydrochloride,
AKOS022181227,
WLN: T6M DNTJ DYR&R DG &GH,
API0001953,
CCG-212523,
HY-112067A,
MCULE-3598783218,
NSC-169496,
NSC-756678,
4CA-0373,
WLN: T6N DNTJ AYR&R DG& D &GH,
LS-111212,
CS-0062684,
FT-0664522,
FT-0697779,
V1811,
J-009887,
SR-05000001920-3,
1-(p-Chlorobenzhydryl)-4-methylpiperazine hydrochloride,
1-(p-Chloro-.alpha.-phenylbenzyl)-4-methylpiperazine hydrochloride,
1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine hydrochloride,
Chlorcyclizine Hydrochloride 1.0 mg/ml in Methanol (as free base),
Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, monohydrochloride,
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, monohydrochloride (9CI),
Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, monohydrochloride (8CI),
Mantadil,
chlorcyclizinehcl,
component of Mantadil,
Piperazine, hydrochloride,
C18H21ClN2.xClH,
UNII-NPB7A7874U,
C18H21ClN2.ClH,
Piperazine, monohydrochloride,
Chlor Cyclizine Hydrochloride,
C18H22Cl2N2,
NPB7A7874U,
C18-H21-Cl-N2.xCl-H,
C18-H21-Cl-N2.Cl-H,
CID62413,
C(c1ccccc1)(c2ccc(Cl)cc2)N3CCN(C)CC3,
Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-, hydrochloride,
894-56-4,
Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-4-methyl-, hydrochloride,
Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-4-methyl-, monohydrochloride,
Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-, monohydrochloride,